Literature DB >> 25031754

Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas.

Akiko Sangawa1, Michiko Shintani2, Naoki Yamao3, Shingo Kamoshida2.   

Abstract

The serine/threonine protein kinase B/Akt plays a central role in the coordination of multiple signal transduction processes involved in transcriptional regulation, cell survival, and apoptosis. Activation of Akt kinase is a prognostic factor in several types of cancers; however, its role in gastrointestinal cancers is not fully understood. Caspase-9 is an Akt substrate that belongs to the caspase family of proteases, which function as initiators of the mitochondrial apoptotic pathway. Little is known about the role of caspase-9 phosphorylation, which downregulates the apoptotic activity of the enzyme. In this study, we investigated the expression of phosphorylated (p)-Akt and phosphorylated (p)-caspase-9 in gastric and colorectal carcinoma and the relationship between p-Akt and p-caspase-9 expression and clinicopathological parameters of gastric and colorectal cancer patients. In total, 75 samples of advanced gastric adenocarcinoma (37 well-to-moderately differentiated and 38 poorly differentiated) and 76 samples of advanced colorectal adenocarcinoma (69 well-to-moderately differentiated and 7 poorly differentiated) were analyzed for p-Akt and p-caspase-9 expression by immunohistochemistry. Our results reveal a correlation between p-Akt and p-caspase-9 expression in gastric and colorectal cancers. Levels of p-caspase-9 were significantly higher in colorectal cancer than in gastric cancer, indicating tumor-specific regulation. Although the biological role of p-Akt/p-caspase-9 signaling remains unclear, we suggest that phosphorylation of caspase-9 may be a useful tool to assess the state of gastrointestinal cancer and the effects of anti-cancer therapy.

Entities:  

Keywords:  Phosphorylated Akt; apoptosis; cell death pathway; gastrointestinal carcinoma; phosphorylated caspase-9

Mesh:

Substances:

Year:  2014        PMID: 25031754      PMCID: PMC4097285     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

Authors:  Hemant K Roy; Bola F Olusola; Dahn L Clemens; William J Karolski; Anne Ratashak; Henry T Lynch; Thomas C Smyrk
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

Review 2.  Mechanisms and consequences of activation of protein kinase B/Akt.

Authors:  J Downward
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

3.  AKT activation predicts outcome in breast cancer patients treated with tamoxifen.

Authors:  Tove Kirkegaard; Caroline J Witton; Liane M McGlynn; Sian M Tovey; Barbara Dunne; Alison Lyon; John M S Bartlett
Journal:  J Pathol       Date:  2005-10       Impact factor: 7.996

4.  Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients.

Authors:  Eriko Tokunaga; Yasue Kimura; Eiji Oki; Naoyuki Ueda; Motonori Futatsugi; Kojiro Mashino; Manabu Yamamoto; Masahiko Ikebe; Yoshihiro Kakeji; Hideo Baba; Yoshihiko Maehara
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

Review 5.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 6.  Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers.

Authors:  P Michl; J Downward
Journal:  Z Gastroenterol       Date:  2005-10       Impact factor: 2.000

7.  Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

8.  Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis.

Authors:  Seon Young Nam; Hye Seung Lee; Gyung-Ah Jung; Jimi Choi; Sung Jin Cho; Min Kyu Kim; Woo Ho Kim; Byung Lan Lee
Journal:  APMIS       Date:  2003-12       Impact factor: 3.205

9.  Regulation of cell death protease caspase-9 by phosphorylation.

Authors:  M H Cardone; N Roy; H R Stennicke; G S Salvesen; T F Franke; E Stanbridge; S Frisch; J C Reed
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

10.  Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

Authors:  M G Schlieman; B N Fahy; R Ramsamooj; L Beckett; R J Bold
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more
  20 in total

1.  ClC-3 chloride channel modulates the proliferation and migration of osteosarcoma cells via AKT/GSK3β signaling pathway.

Authors:  Shuai Du; Liqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.

Authors:  Zuohui Zhao; Fei Wu; Sentai Ding; Liang Sun; Zhao Liu; Kejia Ding; Jiaju Lu
Journal:  Tumour Biol       Date:  2014-10-15

3.  Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3.

Authors:  Yi Xu; Jian-Yong Zhu; Zhang-Ming Lei; Li-Jun Wan; Xiu-Wen Zhu; Feng Ye; Yan-Yue Tong
Journal:  J Physiol Biochem       Date:  2016-11-10       Impact factor: 4.158

Review 4.  Targeting AKT for cancer therapy.

Authors:  Maryam Shariati; Funda Meric-Bernstam
Journal:  Expert Opin Investig Drugs       Date:  2019-10-12       Impact factor: 6.206

Review 5.  Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?

Authors:  Shikha Satendra Singh; Wei Ney Yap; Frank Arfuso; Shreya Kar; Chao Wang; Wanpei Cai; Arunasalam M Dharmarajan; Gautam Sethi; Alan Prem Kumar
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

6.  Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.

Authors:  Yoo-Kyung Lee; Hyun Hoon Chung; Jae Weon Kim; Yong-Sang Song; Noh-Hyun Park
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia.

Authors:  Zhu-Lan Cai; Chen Liu; Qi Yao; Qing-We Xie; Tong-Tong Hu; Qing-Qing Wu; Qi-Zhu Tang
Journal:  Cell Cycle       Date:  2020-12-14       Impact factor: 4.534

8.  TES inhibits colorectal cancer progression through activation of p38.

Authors:  Huili Li; Kun Huang; Lu Gao; Lixia Wang; Yanfeng Niu; Hongli Liu; Zheng Wang; Lin Wang; Guobin Wang; Jiliang Wang
Journal:  Oncotarget       Date:  2016-07-19

Review 9.  Role of PI3K/Akt signaling pathway in cardiac fibrosis.

Authors:  Wuming Qin; Linghui Cao; Isaac Yaw Massey
Journal:  Mol Cell Biochem       Date:  2021-07-10       Impact factor: 3.396

Review 10.  Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.

Authors:  Ismael Riquelme; Kathleen Saavedra; Jaime A Espinoza; Helga Weber; Patricia García; Bruno Nervi; Marcelo Garrido; Alejandro H Corvalán; Juan Carlos Roa; Carolina Bizama
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.